Jove
Visualize
Contact Us

Related Experiment Videos

Turning a corner on HIV neutralization?

J H Nunberg1, K E Follis, M Trahey

  • 1Montana Biotechnology Center, The University of Montana, Missoula, MT 59812, USA.

Microbes and Infection
|April 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laguna Negra Virus Infection Causes Hantavirus Pulmonary Syndrome in Turkish Hamsters (Mesocricetus brandti).

Veterinary pathology·2015
Same author

Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.

Journal of virology·2001
Same author

Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion.

Biochemistry·2001
Same author

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

Journal of virology·2001
Same author

Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection.

Journal of medical primatology·2000
Same author

Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivo.

Proceedings of the National Academy of Sciences of the United States of America·1999
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Developing an effective HIV vaccine is challenging because current methods fail to produce antibodies that neutralize the virus. New

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Conventional immunogens have historically failed to elicit broadly neutralizing antibodies against primary HIV isolates.
  • HIV vaccine development remains a critical global health challenge due to viral diversity and immune evasion.

Purpose of the Study:

  • To explore the potential of novel 'fusion-competent' immunogens in HIV vaccine design.
  • To investigate if capturing transitional intermediate structures of the HIV envelope protein can improve neutralization efficacy.

Main Methods:

  • Utilizing advanced immunogen design strategies focusing on 'fusion-competent' structures.
  • Evaluating the antibody response elicited by these novel immunogens against primary HIV isolates.

Main Results:

Related Experiment Videos

  • 'Fusion-competent' immunogens demonstrate potential in eliciting neutralizing antibodies.
  • These immunogens capture key transitional states of the HIV envelope protein, a critical step for neutralization.

Conclusions:

  • Novel 'fusion-competent' immunogens represent a promising strategy for developing effective HIV vaccines.
  • Further research into these immunogens could overcome previous limitations in eliciting protective immunity against HIV.